Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 4

Other

ICS and COPD: Time to clear the air

       

Authors Ford PA, Russell R , Barnes PJ

Published 31 July 2009 Volume 2009:4 Pages 289—290

DOI https://doi.org/10.2147/COPD.S7143

Download Article [PDF] 


Paul A Ford, Richard EK Russell, Peter J Barnes

Airway Disease Section, National Heart and Lung Institute, Imperial College, London, UK

The debate about what constitutes the correct treatment for COPD has recently intensified. This discussion has grumbled on ever since the first multicenter trials using inhaled corticosteroids (ICS) in chronic obstructive pulmonary disease (COPD) such as the European Respiratory Society study on chronic obstructive pulmonary disease (EUROSCOP) and Inhaled Steroids in Obstructive Lung Disease (ISOLDE) were published in the late 1990’s and the results of trials such as TORCH (TOwards a Revolution in COPD Health) using combination products has only added to the confusion.

Creative Commons License © 2009 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]